Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Clinical trial NCT03117933 · COMPLETED
Trial details
- NCT number
- NCT03117933
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2021-03-12
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.